FDA in 2017: What to Expect?

Jan
24
2017

Date: January 24, 2017

Time: 12:30PM - 1:30PM

Location: New York, NY

Topics

  • FDA in 2017: What to Expect?

Join Mintz Levin and ML Strategies as we look ahead to 2017 and discuss priorities of the FDA and the potential impact on companies in the health care and life sciences industries.

Topics will include:
  • President-elect Trump’s plans for FDA reform
  • Expected health care activity in the 115th Congress
  • Changing FDA regulatory priorities
  • Practical implications for industry

 

Professionals

  • Joanne S. Hawana

    • Related Industries

  • Health Care

    • Speakers

    Joanne S. Hawana

    Joanne S. Hawana

    Speaker

    Joanne counsels global clients on the regulatory and distribution-related implications when bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized.

    Speaker

    Speaker